Free Account Opening + AMC Free Demat
Loading...

CARE Ratings Buyback vs Marksans Pharma Buyback

Comparision between CARE Ratings Buyback and Marksans Pharma Buyback.

Buyback Details

CARE Ratings Buyback is a Tender Offer buyback proposed to list at BSE, NSE while Marksans Pharma Buyback is a Open Market Through Stock Exchange proposed to list at BSE, NSE.

  CARE Ratings Limited Marksans Pharma Ltd
Logo CARE Ratings Buyback Logo Marksans Pharma Buyback Logo
Type of Buyback Tender Offer Open Market Through Stock Exchange
Listing At BSE, NSE BSE, NSE
Face Value ₹10 per share ₹1 per share
Buyback Price ₹515 per share ₹60 per share
Issue Size 23,68,000 shares
Issue Size (Amount) ₹121.95 Crores ₹60.00 Crores
Buyback Ratio
Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 60 Equity Share out of every 539 Fully paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders 69 Equity Shares out of every 907 Fully paid-up Equity Shares held on the Record Date.
Registrar Kfin Technologies Limited Bigshare Services Pvt Ltd
Lead Managers Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Sundae Capital Advisors
Necessity of the buyback

The Buyback is being undertaken for the following reasons:

(i) optimising returns to shareholders;

(ii) enhancing overall shareholder value.

(iii) achieving optimum capital structure.

(iv) mitigating the effects of short-term market volatility.

(v) enhancing shareholders' confidence.

The buyback is being undertaken for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders.

2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.

Buyback Timetable

CARE Ratings Buyback and Marksans Pharma Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. CARE Ratings Buyback Buyback record date is Sep 14, 2022. Marksans Pharma Buyback Buyback record date is .

  CARE Ratings Limited Marksans Pharma Ltd
Record Date Sep 14, 2022
Offer Open Date Nov 18, 2022 Jul 15, 2022
Offer Closure Date Dec 01, 2022 Jan 14, 2023
Last date for receipt of tender forms Dec 03, 2022
Finalisation of buyback Dec 09, 2022
Last Date for settlment of bids Dec 12, 2022
Last Date for extinguishment of shares Dec 19, 2022

Financial Details and Other Relevent Information

Comparison of CARE Ratings Buyback and Marksans Pharma Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  CARE Ratings Limited Marksans Pharma Ltd
Financial
CARE Ratings Limited Financial Information (Restated)
Period EndedTotal RevenueProfit After Tax
31-Mar-20275.1183.48
31-Mar-21279.7490.97
31-Mar-22274.8276.83
Amount in ₹ Crore
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Lakhs)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 1,53,269.20 1,38,287.61 1,13,453.67
Profit After Tax 18,681.40 23,853.88 12,075.27
Net Worth 1,04,216.44 86,972.58 61,990.88
Reserves and Surplus 99,623.30 82,379.44 57,397.74
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Aug-2022 521.80 452.75 484.72
Jul-2022 492.25 410.60 440.55
Jun-2022 485.35 405.35 437.03

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.10 38.70 44.28
May-2022 53.45 44.50 48.20
Apr-2022 62.35 45.55 55.56
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Aug-2022 522.00 452.20 484.75
Jul-2022 492.00 410.15 440.83
Jun-2022 485.00 406.00 437.16

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.10 38.60 44.15
May-2022 53.50 44.50 48.23
Apr-2022 62.40 45.50 56.03

Comments

Add a public comment...